Greg Freiherr, Industry Consultant
Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | Magnetic Resonance Imaging (MRI)| March 23, 2016

Advanced Visualization and the Future of MR


GE’s recently unveiled cardiac product ViosWorks demonstrates the symbiotic relationship between advanced visualization and MR. (Image courtesy GE Healthcare)

There is something about magnetic resonance (MR). The elegance of its mathematics. How it leverages the electromagnetic spectrum and the concepts of quantum mechanics. Certain … and uncertain. MR is the cat inside Schrödinger's box.

The nature of MR pairs it perfectly with advanced visualization, the acquisition of radio signals sent by atoms, transformed into images of tissue inside the body.

It is little wonder that the future of this modality — more than any other — is being defined by progress in software and the advanced visualization that naturally follows.

GE Healthcare is leveraging a “GPU smart cloud platform” as the means for post-processing MR cardiac. The company’s ViosWorks promises a comprehensive and practical means for providing cardiac anatomy and function. While the company claims the scan might be completed in as little as eight minutes, with the patient breathing freely, scans in reality may take up to 20 minutes. They will not, however, require a technologist expert in the performance of the scan or highly and especially trained clinicians, according to GE. The company, in fact, is framing exams with ViosWorks as simplified and requiring no particular supervision.

Toshiba’s dedicated MR sequence for pulmonary imaging is another example of the unique relationship between MR and advanced visualization. This sequence, called ultrashort echo time (UTE), visualizes what is all but invisible using conventional MR. Pulmonary images obtained using UTE were remarkably similar to those obtained of the lung using CT, as indicated by images from the two modalities placed side-by-side at the last RSNA.

The growth potential of these applications — MR lung in place of CT; MR cardiac in place of cardiac cath — is obvious in this age of heightened concern about exposing patients to ionizing radiation.

New techniques and protocols for MR abdominal scanning, as well as for the prostate, promise to increase procedure volume above and beyond historical trends. Ditto for time-saving protocols, such as Siemens’ GoBrain and Simultaneous Multi-Slice (SMS), which the company claims will dramatically reduce the time needed for MR brain scans. (GoBrain provides validated “push-button” brain exams that can be done in five minutes; SMS acquires human slices simultaneously rather than sequentially, as is done conventionally.)

Variants of Philips’ mDIXON provide images with multiple contrasts, each coming from a single scan; Philips’ ScanWise Implant, that reduce or eliminate artifacts, while optimizing scan time through the use of an MR-guided user interface and automatic scan parameter selection. (ScanWise is designed specifically for patients with knee, hip and spine implants, as well as pacemakers.)

MR has already carved a niche in breast imaging, thanks to software advances. MR breast visualization packages support processing in four dimensions. Dynamic 3-D presentation and data analysis tools automate lesion analysis and chest wall removal, while transferring data to BI-RADS reports. Hologic’s MultiView software captures the washing in and out of a contrast medium into regions of interest in the breast as it colorizes diffusion apparent diffusion coefficient (ADC) maps to help identify highly diffused areas.

Less well known but commercially available are software packages that localize cancer tumors for use in MR-based simulations of radiotherapy. A product available from GE, AdvantageSim MD, includes iso center marking and beam planning tools, as well as the means for contouring at-risk organs and plotting, and respiratory induced motion.

While it may not be surprising that MR provides fertile ground for such a range of visualizations, the matchless wonder of this modality is grounds for at least momentary reflection on what has been achieved. It offers just a sampling of what is yet to come.

Editor’s note: This is the fourth blog in a series of four by industry consultant Greg Freiherr on MR Balances Speed and Clinical Reach. To read MR is About to Get Faster, Cheaper and More Valuable: It's About Time, click here; to read The Unsettling Evolution of Advanced Visualization, click here, and to read “How Increased Productivity Might Pave the Way to Personalized Medicine,” click here.

Revision note: The post-processing for ViosWorks, a partnership with Arterys, will be done on a GPU smart cloud platform, not on the GE Health Cloud, as was initially stated in this blog. As of April 6, the time of this revision, ViosWorks is not commercially available.

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...
A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse

Figure 1. A high-fidelity 3-D tractography of the left ventricle heart muscle fibers of a mouse from Amsterdam Ph.D. researcher Gustav Strijkers.

News | Magnetic Resonance Imaging (MRI) | June 07, 2019
The Amsterdam University Medical Center has won MR Solutions’ Image of the Year 2019 award for the best molecular...